Totals
- Total revenue
- $651,672
- Total expenses
- $307,430
- Contributions and grants received
- $629,886
- Grants paid
- $123,984
- Program service revenue
- $0
- Investment income
- $21,786
- Other revenue
- $0
- Total assets, end of year
- $1,315,374
- Total liabilities, end of year
- $0
- Net assets or fund balances, end of year
- $1,315,374
- Program services expenses (Part IX)
- $307,430
- Management and general expenses
- $0
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $307,430
Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1a · Federated campaigns
$0
-
1b · Membership dues
$0
-
1c · Fundraising events
$0
-
1d · Related organizations
$0
-
1e · Government grants (contributions)
$0
-
1f · All other contributions, gifts and grants
$629,886
-
1g · Noncash contributions included above
$60,411
-
3 · Investment income
total $21,786 · related or exempt $21,786 · unrelated business $0 · excluded $0
-
4 · Income from investment of tax-exempt bond proceeds
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
5 · Royalties
total $0 · related or exempt $0 · unrelated business $0 · excluded $0
-
6c · Rental income or loss
real property $0 · personal property $0
-
7c · Gain or loss
securities $0 · other assets $0
-
8a · Fundraising events: contributions included on line 1c
$0
-
11e · Other revenue, total
$0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $123,984 · program services $123,984
-
2 · Grants to domestic individuals
total $0
-
5 · Compensation of officers, directors and key employees
total $50,000 · program services $50,000
-
7 · Other salaries and wages
total $2,250 · program services $2,250
-
11c · Fees: accounting
total $1,480 · program services $1,480
-
11g · Fees: other
total $17,784 · program services $17,784
-
13 · Office expenses
total $1,385 · program services $1,385
-
14 · Information technology
total $5,729 · program services $5,729
-
17 · Travel
total $8,474 · program services $8,474
-
19 · Conferences, conventions and meetings
total $92,801 · program services $92,801
-
23 · Insurance
total $3,160 · program services $3,160
-
24a · Other expenses: MISC EXPENSES
total $79 · program services $79 · management and general $0 · fundraising $0
-
24b · Other expenses: BANK FEES
total $175 · program services $175 · management and general $0 · fundraising $0
-
24c · Other expenses: PAYROLL PROCESSING
total $129 · program services $129 · management and general $0 · fundraising $0
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $808,054 · end of year $565,296
-
2 · Savings and temporary cash investments
beginning of year $0
-
3 · Pledges and grants receivable
end of year $0
-
4 · Accounts receivable
beginning of year $78 · end of year $78
-
5 · Loans and receivables from officers and key people
end of year $0
-
6 · Loans and receivables from disqualified persons
end of year $0
-
7 · Other notes and loans receivable
end of year $0
-
8 · Inventories for sale or use
end of year $0
-
9 · Prepaid expenses and deferred charges
end of year $0
-
13 · Investments: program-related
beginning of year $150,000 · end of year $750,000
-
25 · Other liabilities
beginning of year -$13,000
-
27 · Net assets without donor restrictions
beginning of year $536,465 · end of year $942,707
-
28 · Net assets with donor restrictions
beginning of year $434,667 · end of year $372,667
Mission and programs · 2025
Mission
PROVIDE FUNDING TO RARE DISEASE RESEARCH AND SUPPORT AFFECTED FAMILIES
-
Cure LBSL's primary mission is to fund critical research into Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation (LBSL), a rare genetic leukodystrophy. During 2025, the organization supported research initiatives designed to improve understanding of the disease, advance scientific knowledge of disease progression, and explore potential therapeutic approaches. Activities included support for natural history and qualitative patient studies as well as collaborations with academic and clinical research partners.
Expenses $214,629 · Grants $141,768
-
Cure LBSL conducted an Externally-Led Patient Focused Drug Development meeting on August 1, 2025. This advocacy initiative gathered patient and caregiver perspectives regarding the impact of LBSL and provided information intended to support regulatory and therapeutic development efforts.
Expenses $92,801
As filed on the 2025 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Morgan VoigtMORGAN VOIGT
EXECUTIVE DIRECTOR
- Total calculated
- $50,000
- From this org
- $50,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 30
-
Lance SternLANCE STERN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Megan MitchellMEGAN MITCHELL
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Chris GulugianCHRIS GULUGIAN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Edward BlakelyEDWARD BLAKELY
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
-
Elizabeth McGinnELIZABETH MCGINN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 15
-
Elizabeth GulugianELIZABETH GULUGIAN
BOARD CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
Morgan SternMORGAN STERN
DIRECTOR
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
$123,984
Research
Provenance
- Return type
- form_990
- Tax year
- 2025
- Filed
- 9 September 2026
- IRS schema version
- 2025v4.0
- Source object
- 202622539349301602
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.